Pheniramine

CHEMBL1193 Phase 4 अनुमोदित Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
240.3 g/mol
LogP
2.8
Phase
4

Pheniramine is a first-generation antihistamine of the propylamine class that competitively antagonizes H1 histamine receptors to reduce allergic symptoms, and also possesses anticholinergic and mild sedative properties. It is used in combination products for symptomatic relief of allergic conditions, common cold symptoms, and nausea.

आणविक भार

240.3400 g/mol

LogP

2.80

TPSA

16.10 Ų

लिपिंस्की RO5

उत्तीर्ण

चिकित्सीय क्षेत्र

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D संरचना

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN(C)CCC(c1ccccc1)c1ccccn1

InChI

InChI=1S/C16H20N2/c1-18(2)13-11-15(14-8-4-3-5-9-14)16-10-6-7-12-17-16/h3-10,12,15H,11,13H2,1-2H3

Molecular Formula

C16H20N2

HBD / HBA

- / 2

घूर्णनीय बंधन

5

भारी परमाणु

18

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

अक्सर पूछे जाने वाले प्रश्न

Pheniramine is a first-generation antihistamine of the propylamine class that competitively antagonizes H1 histamine receptors to reduce allergic symptoms, and also possesses anticholinergic and mild sedative properties. It is used in combination products for symptomatic relief of allergic conditions, common cold symptoms, and nausea.

Yes, Pheniramine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1193. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4761. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.